Brief: Centessa Pharmaceuticals Ltd Adss Open 1.25% Above IPO Price In Nasdaq Debut
May 28 (Reuters) -
* CENTESSA PHARMACEUTICALS LTD ADSS OPEN AT $20.25 IN NASDAQ
DEBUT
VERSUS IPO PRICE OF $20.00/ADS
Further company coverage: CNTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1